Lattice Therapeutics
Washington, US · Founded 2020 · Delaware corporation
Founders & leadership
PM
Patrick Michael McTamneyNamed on SEC filing
JG
Jack Guy DaSilvaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2022
▶$300KraisedJun 2022 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedJun 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick Michael McTamneyExecutive Officer, Director
- Jack Guy DaSilvaDirector
- Offering amount
- $900K
- Amount sold
- $300K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lattice Therapeutics raised?
- Lattice Therapeutics has disclosed $300K raised across 1 round.
- Where is Lattice Therapeutics headquartered?
- Lattice Therapeutics is headquartered in Washington, US.